MTOR and neoplasm: miR‐122 indirectly promotes the activation of the PI3K/AKT/mTOR pathway by suppressing the expression of tumor suppressor genes, such as SPRY2, thereby relieving the inhibition of the Rat sarcoma (Ras)/mitogen‐activated protein kinase (MAPK) pathway.39, 40